Stada Group
Nikola Veizovic is a finance professional with extensive experience in financial control and strategic management within various companies. Currently serving as CFO for Eastern Europe at STADA Group and also acting as Finance Business Partner for Europe, Nikola has previously held significant roles at Hemofarm A.D., including Head of Controlling Department and Strategic Controlling Manager, where responsibilities included monitoring business operations and defining corporate strategies. Other notable positions include Financial Controller at Al Rawafed Serbia and Team Leader in Management Reporting at Air Serbia. Nikola's career began at PwC as an Assurance Senior Associate, where leadership in audits and compliance was demonstrated, along with expertise in IFRS training. Educational qualifications include ACCA candidacy and a Bachelor's degree in Finance, Banking, and Insurance from the Faculty of Economics and Business, University of Belgrade.
This person is not in any teams
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.